Infinity Pharmaceuticals Stock (OTC: INFIQ)

Latest news for Infinity Pharmaceuticals (OTC:INFIQ) Stock

Infinity Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology related treatments. The company operates in only one segment which is drug development.

INFINITY PHARMS INC by Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals Inc

Alaska Air Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.39 by 6.69 percent. This is a 15 percent decrease over earnings of $3.00 per share from the same period last year. The company reported quarterly sales of $2.897 billion which missed the analyst consensus estimate of $2.945 billion by 1.62 percent. This is a 2.08 percent increase over sales of $2.838 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

Alaska Air Q2 2024 Adj EPS $2.55 Beats $2.39 Estimate, Sales $2.897B Miss $2.945B Estimate

Scotiabank analyst Andres Coello maintains America Movil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>) with a Sector Perform and lowers the price target from $19 to $18.9.

Price Target

Analyst Ratings

Scotiabank Maintains Sector Perform on America Movil, Lowers Price Target to $18.9

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares closed slightly higher Wednesday amid a tumultuous trading day <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39823332/nasdaq-100-suffers-worst-day-in-11-months-as-chipmakers-tumble-on-china-curbs-magnificent-">for the semiconductor sector. </a>
<h1 class="wp-block-heading">What To Know</h1>
Semiconductor stocks moved lower Wednesday as investors digested a report about the expansion of export restrictions and ASML Holding NV&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) earnings release and forward guidance. 
ASML shares fell more than 12% on the session after the company reported <a href="https://www.benzinga.com/news/earnings/24/07/39808860/asml-beats-q2-earnings-expectations-with-strong-china-sales-ai-chip-demand">second-quarter numbers</a> that were lower than the same period in the previous year and guided quarterly gross margin in the range of 50% to 51% versus expectations of 51.1%.
Investors also mulled a Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-07-17/us-considers-tougher-trade-rules-against-companies-in-chip-crackdown-on-china">report</a> that the Biden administration is considering imposing the most severe trade restrictions on China if companies continue giving the country access to advanced semiconductor technology.
Additionally, former President Donald Trump said Taiwan should pay the U.S. for its defense, casting more doubt on the stability of the region. 
&#8220;I know the people very well, respect them greatly. They did take about 100% of our chip business. I think, Taiwan should pay us for defense,&#8221; Trump said in the Bloomberg Businessweek interview, published Tuesday.
Read Next:<a href="https://www.benzinga.com/news/24/07/39796841/lucids-stock-drives-higher-on-2025-model-year-updates-whats-going-on"> Lucid&#8217;s Stock Drives Higher On 2025 Model Year Updates: What&#8217;s Going On?</a>
Investors may view Intel as a safer option, compared to peers including Taiwan Semiconductor Manufacturing Company, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) and NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), which depend on Taiwan for manufacturing. Intel <a href="https://www.intel.com/content/www/us/en/corporate/usa-chipmaking/home.html">said it expects </a>to invest more than $100 billion in the U.S. to expand its manufacturing capacity and capabilities in Arizona, New Mexico, Oregon and Ohio with support from the CHIPS act. 
Intel is set to report its second-quarter results on Aug. 1 after the closing bell. According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect the company to report earnings of 10 cents per share and quarterly revenue of $12.948 billion.
<h1 class="wp-block-heading">INTC Stock Prediction 2024</h1>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of Intel have an average 1-year price target of $34.86, representing an expected upside of 1.51%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. Four analysts have bearish recommendations on Intel, while one analyst has bullish ratings. The street high price target from Mizuho is $45, while the street low from Rosenblatt is $17.
INTC Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Intel Corporation ended Wednesday's session up 0.35% at $34.46.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39805320/what-happened-with-canopy-growth-stock-today">What Happened With Canopy Growth Stock Today?</a></li>
</ul>
Image: Shutterstock

Global

Movers

Tech

ASML

INTC

NVDA

What Happened With Intel Stock Today?

Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.49 by 6.12 percent. This is a 1.96 percent increase over earnings of $0.51 per share from the same period last year. The company reported quarterly sales of $254.596 million which beat the analyst consensus estimate of $247.208 million by 2.99 percent. This is a 0.99 percent decrease over sales of $257.152 million the same period last year.

HOMB

Home BancShares Q2 2024 Adj EPS $0.52 Beats $0.49 Estimate, Sales $254.596M Beat $247.208M Estimate

Citigroup analyst Michael Ward maintains Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) with a Neutral and lowers the price target from $232 to $225.

Citigroup Maintains Neutral on Progressive, Lowers Price Target to $225

Citigroup analyst Thomas Palmer maintains Kraft Heinz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) with a Buy and lowers the price target from $42 to $38.

Citigroup Maintains Buy on Kraft Heinz, Lowers Price Target to $38

1-800-Flowers.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLWS#NASDAQ">FLWS</a>) stock closed Wednesday at $10.00 per share, down more than 9%.
The company could miss the sales estimate for the fourth quarter of fiscal 2024 and issue its fiscal 2025 guidance below Street expectations, according to DA Davidson.
The 1-800-Flowers Analyst: Linda Bolton Weiser downgraded coverage of 1-800-Flowers from Neutral to Underperform, while reducing the price target from $11 to $8.
The 1-800-Flowers Thesis: Bloomberg debit card data, which is 94% correlated to sales, indicates a decline of 15% year-on-year in sales in the fourth quarter of fiscal 2024, versus a 13% decline in the prior quarter F3Q24, Weiser said in the downgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
This suggests that the consensus estimate of a 6% year-on-year decline in the fiscal fourth-quarter sales may prove to be too high, she added.
The University of Michigan consumer sentiment index, which is currently in the 60s-70s, needs to be consistently above 80 for 1-800-Flowers to return to low-single-digit sales growth, the analyst added.
"Consumers have tended to show up more on the big gift-giving holidays like Mother&#8217;s Day, but FLWS&#8217; everyday gifting business (which is the majority of sales) has been very anemic," she further wrote.
FLWS Price Action: Shares of 1-800-Flowershad declined by 9.09% to $10.00 at the time of publication on Wednesday.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/07/39827103/dow-jones-extends-all-time-highs-blue-chips-post-strongest-6-day-gain-versus-tech-stocks-in-22-years">Dow Jones Extends All-Time Highs: Blue Chips Post Strongest 6-Day Gain Versus Tech Stocks In 22 Years</a></li>
</ul>
Image: Shutterstock

Analyst Color

Short Ideas

Downgrades

Trading Ideas

FLWS

1-800-Flowers Analyst Warns Bloomberg Debit Card Data Shows Unfavorable Trends

UnitedHealthcare has served Rhode Islanders through the MMCS program since 1993; this contract award will continue to provide access to UnitedHealthcare coverage and services through 2030.

Contracts

UnitedHealthcare Says Selected By The State Of Rhode Island To Serve Medicaid Members Through MMCS Program; This Contract Award Will Continue To Provide Access To Coverage And Services Through 2030

Citigroup analyst Thomas Palmer maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Neutral and raises the price target from $124 to $129.

FRPT

Citigroup Maintains Neutral on Freshpet, Raises Price Target to $129

Synovus Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $0.86 by 34.88 percent. This is unchanged from the same period last year. The company reported quarterly sales of $306.147 million which missed the analyst consensus estimate of $429.042 million by 28.64 percent. This is a 46.08 percent decrease over sales of $567.807 million the same period last year.

Synovus Finl Q2 2024 Adj EPS $1.16 Beats $0.86 Estimate, Sales $306.147M Miss $429.042M Estimate

Citigroup analyst Thomas Palmer maintains Hershey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) with a Neutral and lowers the price target from $204 to $188.

Citigroup Maintains Neutral on Hershey, Lowers Price Target to $188

Citigroup analyst Keith Horowitz maintains Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) with a Neutral and raises the price target from $98 to $105.

Citigroup Maintains Neutral on Morgan Stanley, Raises Price Target to $105

Beyond Meat Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) shares are crumbling in Wednesday&#8217;s after-hours session as investors digest a report suggesting the company&#8217;s <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39799604/short-idea-alert-beyond-meat-shake-shack-plus-one-semiconductor-stock-analysts-have">liquidity position has weakened</a>.
What Happened: According to a Wall Street Journal <a href="https://www.wsj.com/articles/beyond-meat-engages-bondholders-for-restructuring-talks-7de6b8ae?mod=Searchresults_pos1&amp;page=1">report</a> published after the market close on Wednesday, Beyond Meat has reached out to a group of bondholders to start discussions about a potential restructuring of its balance sheet.
People familiar with the matter reportedly said the group of bondholders, which own some of Beyond Meat&#8217;s $1.1 billion of convertible notes, are working with law firm Akin Gump Strauss Hauer &amp; Feld on the matter. 
Beyond Meat stock has been stuck in a downtrend since the summer of 2021 as the company continues to burn through cash. The plant-based meat company had $173.5 million in cash and cash equivalents&nbsp;as of March 30. 
Don&#8217;t Miss: <a href="https://www.benzinga.com/news/earnings/24/07/39825869/united-airlines-q2-earnings-revenue-miss-eps-beat-guidance-unchanged-and-more">United Airlines Q2 Earnings: Revenue Miss, EPS Beat, Guidance Unchanged And More</a>
In Beyond Meat&#8217;s most recent earnings report, the company noted its operating environment continued to be affected by uncertainty related to macroeconomic issues including &#8220;ongoing, further weakened demand in the plant-based meat category.&#8221;
Beyond Meat is due to report earnings again in early August, although a date has not yet been confirmed by the company. According to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>, analysts are anticipating a loss of 51 cents per share on revenue of $87.808 million.
BYND Price Action: Beyond Meat shares were down 16.32% after hours at $6 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39821442/netflix-q2-earnings-preview-can-ad-supported-growth-new-releases-sustain-investor-h">• Netflix Q2 Earnings Preview: Can Ad-Supported Growth, New Releases Sustain Investor Hype?</a>
Photo: Courtesy of Beyond Meat.

Restaurants

After-Hours Center

BYND

Beyond Meat Stock Is Getting Cooked After The Close: What's Going On?

Citigroup analyst Stephen Trent maintains Frontier Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>) with a Neutral and lowers the price target from $7 to $5.35.

ULCC

Citigroup Maintains Neutral on Frontier Group Holdings, Lowers Price Target to $5.35

The Dow Jones Industrial Average Index reached a new record high of 41,198 points Wednesday, closing 0.6% higher and extending its winning streak to six <a href="https://www.benzinga.com/topic/dow-jones-industrial-average">consecutive sessions in the green</a>.
Blue-chip stocks, tracked by the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>), found a strong ally in July&#8217;s seasonality. Just a year ago, the Dow Jones began a remarkable bull run of 13 consecutive sessions starting on July 10.
This year&#8217;s Dow rally is distinguished not only by new record highs but by its outperformance relative to the tech sector.
Over the last six sessions, the Dow Jones has risen by 5%, while the tech-heavy Nasdaq 100 fell by 3.3%. Therefore, it has outperformed the Nasdaq 100 by 8.3 percentage points in the most recent six sessions.
To find another six-day period where blue chips outpaced tech by such a margin, we have to go back to July 2002. 
<h3 class="wp-block-heading">Dow Jones Vs. Nasdaq 100</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="456" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/17162751/image-29-1024x456.png" alt="" class="wp-image-441691" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/17162751/image-29-1024x456.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/17162751/image-29-300x134.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/17162751/image-29-768x342.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/17162751/image-29-1536x684.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/17162751/image-29.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
There is currently a &#8220;general enthusiasm about cyclical sectors like industrials and materials that tend to perform best in a growing economy,&#8221; Joe Mazzola, director of trading and education at Charles Schwab. &#8220;Hopes for Fed rate cuts starting in September triggered a major rotation toward those sectors starting late last week.&#8221;
&#8220;Dow&nbsp;Jones Industrial Average breaking out to new highs to suggest that the summer 2024 rally is getting healthier,&#8221; Stephen Suttmeier, CFA, CMT.
<h3 class="wp-block-heading">Top 5 Blue-Chip Stock Performers Of Last 5 Sessions</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Price Chg. % (5D)</td>
</tr>
<tr>
<td>UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</td>
<td>14.43%</td>
</tr>
<tr>
<td>Caterpillar Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>)</td>
<td>8.91%</td>
</tr>
<tr>
<td>The Home Depot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>)</td>
<td>8.11%</td>
</tr>
<tr>
<td>Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</td>
<td>7.16%</td>
</tr>
<tr>
<td>The Travelers Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>)</td>
<td>6.47%</td>
</tr>
</tbody>
</table>
</figure>
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39823332/nasdaq-100-suffers-worst-day-in-11-months-as-chipmakers-tumble-on-china-curbs-magnificent-">Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What&#8217;s Driving Markets Wednesday?</a></li>
</ul>
Image: Shutterstock

Markets

SPDR Dow Jones Industrial Average ETF Trust

Dow Jones Extends All-Time Highs: Blue Chips Post Strongest 6-Day Gain Versus Tech Stocks In 22 Years

MEOH

Methanex, Entropy Enter Agreement To Invest In Pre-FEED Study For Carbon Capture, Utilization And Sequestration Deployment At Alberta Facility

Citigroup analyst Keith Horowitz maintains PNC Finl Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) with a Buy and raises the price target from $175 to $200.

Citigroup Maintains Buy on PNC Finl Servs Gr, Raises Price Target to $200

Rhame has agreed to continue supporting Vertex in a consulting role through the end of 2024. Upon Rhame&#39;s retirement, Doug Haugh, Vertex&#39;s Chief Commercial Officer, will also assume the role of interim Chief Operating Officer.

Management

VTNR

Vertex Energy Says James Rhame Will Be Retiring As COO, Effective July 25, 2024; Doug Haugh Named As Interim COO

Citigroup analyst Tyler Radke maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and raises the price target from $909 to $911.

Citigroup Maintains Buy on ServiceNow, Raises Price Target to $911

Ratings for AppFolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPF#NASDAQ">APPF</a>) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $278.67, a high estimate of $328.00, and a low estimate of $238.00. This current average reflects an increase of 9.28% from the previous average price target of $255.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1721250088_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of AppFolio by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alexei Gogolev</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$328.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$295.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$295.00</td>
<td>-</td>
</tr>
<tr>
<td>John Campbell</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$241.00</td>
<td>$241.00</td>
</tr>
<tr>
<td>Ryan Tomasello</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$238.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Jason Celino</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$275.00</td>
<td>$264.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to AppFolio. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AppFolio compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of AppFolio's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into AppFolio's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/APPF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on AppFolio analyst ratings.</a>
<h2>Unveiling the Story Behind AppFolio</h2>
AppFolio Inc is a provider of cloud-based software solutions for real estate industry. Its property management software provides property managers with an end-to-end solution to their business needs. Its products include cloud-based property management software (Appfolio Property Manager). It also offers value-added services, such as screening, risk mitigation and electronic payment services. The business activity of the firm predominantly functions through the United States and it generates revenue in the form of subscription fees.
<h3>Financial Milestones: AppFolio's Journey</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: AppFolio's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately 37.71%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: AppFolio's net margin excels beyond industry benchmarks, reaching 20.63%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 12.15%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 9.12%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.13, AppFolio adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APPF

Forecasting The Future: 6 Analyst Projections For AppFolio

Biotech bankruptcies hit a record despite sector's recovery

ATHXQ

BIOCQ

CFRXQ

GLSHQ

HGENQ

IMPLQ

INFIQ

MEIP

ONCSQ

PRED

SRNEQ

THER

Legal

Press Releases

INFI MONDAY DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI

INFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Infinity Pharmaceuticals

News

Latest news for Infinity Pharmaceuticals (OTC:INFIQ) Stock